CardioScape: project overview
› CardioScape - a survey of the European cardiovascular research landscape and recommendations for future research strategy - is a 23 month project funded by the European Union FP7 research programme.
› CardioScape aims to outline the current CVD research and innovation landscape across Europe towards establishing the extent of duplication across national research programmes and the existence of gaps that reduce opportunities for innovation.
› The lead CardioScape project partner is the European Society of Cardiology (ESC), representing over 80,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
› PNO, Europe’s leading independent innovation grants consultancy, is the second project partner. Founded in 1985, PNO is Europe’s largest independent public funding advisory, annually raising over €250 million on behalf of its clients.
› 157 organisations from all EU Member States were invited to report information on the funding provided for cardiovascular research. The accurateness of the CardioScape data and of the analysis in this report is based on the assumption that the information received was truthful.
CardioScape: the first-ever database on CVD research in Europe
› The CardioScape database provides a snapshot of cardiovascular research project grants ≥ € 100 000 for the period 2010 – 2012 in the European Union. It is covering funding schemes that are directly accessible to all researchers, but not strategic research funding directed at institutions or specific research consortia within a national context.
› CardioScape’s findings should be interpreted cautiously, because there is not necessarily a strong correlation between the level of funding for a specific topic and the impact this has on human health and the wealth of the economy.
› Although industry funding for cardiovascular research represents an important share of the overall available funding for research at a European and national level it was not possible to collect such data in the CardioScape project.
› An exhaustive inventory of EU funding for cardiovascular research was not within the scope of the CardioScape project. Information on FP7 funding in 2010, 2011 and 2012 is referenced in this report as means of comparison with sources of national funding.
› European and national funding bodies and scientists from all areas of cardiovascular research may access the CardioScape database, which is freely available to the whole scientific community, to understand who is doing what research and where and funded by whom.
› Automatic computer classification allowed the continuous categorisation of new entries from different sources into the common CardioScape taxonomy of research (see Annex 4), which was developed uniquely by experts for the CardioScape project. Stakeholders are able to populate the CardioScape database with their own project information by contacting the CardioScape team through the website (www.cardioscape.eu).
› Using a web-based user interface, the data can be interrogated from very different viewpoints by different types of users (e.g. policymakers, funding bodies, researchers): Does funding for clinical cardiovascular research in Europe correspond to population size? Are the obvious gaps in funding for a specific field in a specific country? Which projects on the use of a certain approach are currently funded in Europe?
› Data collection, classification and interrogation processes developed for CardioScape could be expanded to other relevant areas of medical research in Europe.
› CardioScape is an incentive for researchers and funding bodies to include new data in the database, in order to maintain an up to date European picture of cardiovascular funding. Overall, this will improve the extent and quality of knowledge on cardiovascular research funded and performed in the EU.
CardioScape: a picture of the CVD research landscape in Europe
› At least €876 million was awarded for CVD research project grants under competitive open funding schemes in the EU over a three years period (2010 – 2012)
› 2/3 (€ 618 M) of surveyed CVD research funding comes from national sources (government/public and charity/private), while the remaining 1/3 (€ 258 M) comes from the EU. National funding sources appear as key for research performed within national borders and find an important complement in EU funding that focuses on transnational cardiovascular research.
› 130 funding organisations, government/public and charity/private, fund CVD research across the EU-28
› Government/public funding in cardiovascular research in Europe accounts for 53% of total grants awarded, excluding EU funding. Charity/private agencies provide 47% of cardiovascular research funding in Europe.
› One funding agency alone, the British Heart Foundation, accounts for 14% of total funding in CVD research, including EU funding, and 22% of CVD research funding across EU-28 excluding EU funding.
› 3 funding agencies account for over 50% of nationally provided competitive grant funding dedicated to CVD research.
› Only 3 charity/private agencies have budgets higher than €10 million for CVD research in 2010-2011-2012
› 7 government/public agencies have budgets above €10 million for CVD research in 2010-2011-2012
› Although CVD is the most common cause of death in EU, research funding is larger for cancer: €2.25 billion over three years (latest available data from 2002-2003)
› Research spend is highest for the area of human/clinical research, which generally entails much higher costs than basic research, and lowest for research in prevention/population/public health.
To download the full report of the CardioScape project click here